观点:如何测量类风湿性关节炎患者的并发症 - 临床和学术价值
1Division of Rheumatology, Department of Internal Medicine III, Medical University Vienna, Vienna, Austria.
Rheumatology (Oxford, England)
|October 23, 2023
概括
并发症显著影响类风湿性关节炎 (RA) 患者. 测量这些同时存在的疾病需要根据临床或研究需求仔细选择适当的并发症指数.
科学领域:
- 类风湿病学 类风湿病学
- 临床流行病学临床流行病学
背景情况:
- 伴随性疾病在类风湿性关节炎 (RA) 中普遍存在,并显著影响患者的治疗结果.
- 量化并存疾病的负担对于了解RA患者的整体健康状况至关重要.
- 目前,没有普遍接受的标准来衡量RA的并发症.
研究的目的:
- 讨论与类风湿性关节炎患者共患病的测量的重要性和挑战.
- 突出共存疾病指数在评估共存疾病影响中的作用.
- 根据特定的研究或临床意图指导选择适当的并发症测量工具.
主要方法:
- 审查现有的关于RA的并发症指数的文献.
- 对概念差异和指数开发设置变化的分析.
- 讨论影响选择并发症测量工具的因素.
主要成果:
- 针对RA患者,已开发出广泛的并发症指数.
- 不同的指数由于不同的发展环境而表现出不同的概念变化.
- 选择一种并发症指数在很大程度上取决于预期的应用 (临床与研究) 和具体的研究问题.
结论:
- 准确测量并发症对于有效管理和研究RA至关重要.
- 选择并发症指数应根据具体的临床或研究背景进行调整.
- 对选择适当的并发症指数的进一步标准化或指导可能有利于RA研究和实践.
相关概念视频
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
37
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
37
Rheumatic Heart Disease III: Medical Management
11
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
11
Rheumatic Heart Disease I: Introduction
14
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
14
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
11
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
11
Rheumatic Heart Disease IV: Nursing Management
15
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
15
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
14
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
14


